E-Z-EM’s IRiS 2.0, the latest version of its Injector Reporting information System (IRiS) software package, helps turn E-Z-EM Empower injectors into an integrated data management network.

The patent-pending networking solution for the CT or MR suite lets clinicians track patient ID, creatinine values, GFR (MDRD and Cockcroft-Gault), type of contrast, consumable utilization, E-Z-EM’s exclusive extravasation detection accessory (EDA) and the number of EDA-identified extravasations. All information can reportedly be accessed from the convenience of the desktop. Data can be readily displayed and easily exported to the Microsoft Office Suite for further review, saving reporting and analysis time. Data may be viewed in daily, monthly or 12-month format.

October 2007


Additional Content

News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Cardiac Imaging

Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...

Time August 12, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
Subscribe Now